Trial Condition(s):

Endometriosis

Efficacy and safety of SH T00660AA in treatment of endometriosis

Bayer Identifier:

91233

ClinicalTrials.gov Identifier:

NCT00225199

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The purpose of this study is to demonstrate safety and efficacy of SH T00660AA compared to placebo in the treatment of endometriosis

Inclusion Criteria
- Female patients with endometriosis-associated pelvic pain
Exclusion Criteria
- Pregnant or lactating women
 - history or suspicion of hormone dependent tumor
 - therapy resistant endometriosis
 - need for primary surgical treatment
 - any other conditions which forbid the participation

Trial Summary

Enrollment Goal
198
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
Yes
Products
Visanne (Dienogest, BAY86-5258)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design